Zolmitriptane as Prophylaxis for Chilhood Migraine

Zolmitriptane as Prophylactic Therapy Childhood Migraine

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06089356

Enrollment

Registered

2023-10-18

Start date

2023-01-01

Completion date

2024-01-01

Last updated

2023-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Brief summary

zolmitriptane can be tried as prophylactic therapy of childhood migraine

Detailed description

90 children with migraine included in the study first group 30 received zolmitriptane second group 30 received topiramate third group 30 received valproate

Interventions

DRUGzolmitriptanee

zolmitriptane tablet daily

DRUGtopiramate

topiramate once daily

DRUGValproate

valproate once daily

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

8 Years to 18 Years

Healthy volunteers

Inclusion criteria

children with migraine -

Exclusion criteria

those who suffer from ischemic heart disease , or who have allergy to any of drugs used \-

Design outcomes

Primary

Measure	Time frame
number and severity of migraine attacks	6 months

Countries

Egypt

Contacts

Primary Contactabeer salamah, ass prof

abeersalamah84@yahoo.com00201009221243

Backup Contactabeer salamah, ass prof

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026